Shares of Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) traded up 2.1% on Thursday . The company traded as high as $3.6380 and last traded at $3.6165. 27,062 shares were traded during mid-day trading, an increase of 100% from the average daily volume of 13,527 shares. The stock had previously closed at $3.5430.
Medexus Pharmaceuticals Price Performance
The firm’s 50-day moving average is $3.63 and its two-hundred day moving average is $3.08.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
Recommended Stories
- Five stocks we like better than Medexus Pharmaceuticals
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
- MarketBeat Week in Review – 09/14 – 09/18
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
